Shield Therapeutics No Longer Expects 2026 Operating Profitability
The company no longer expects the group to achieve operating profitability for the year ending 31 December 2026.
Related stories
Philips Beats Profit Forecasts, Reaches Respironics Agreement in Principle in US
M impact | EARNINGS | Nov 03, 2026, 08:05 AM UTC
AB Foods Forecasts Further Profit Decline as Sugar Losses Worsen
M impact | EARNINGS | Nov 03, 2026, 08:05 AM UTC
Cherry Targets Peripherals Operational Profitability From 2027
Cherry SE is restructuring its Peripherals business and reducing jobs, targeting operational profitability from 2027. Preliminary, unaudited nine-month 2026 revenue fell to €58.9 m
M impact | EARNINGS | Nov 03, 2026, 08:03 AM UTC
OVB Holding Raises 2026 Brokerage Income Guidance After Nine-Month Results
OVB reported brokerage income of €361.4 million for the first nine months of 2026, up 11.8% from the previous period. EBIT rose 83.3% to €11.4 million and EPS was €0.73. The compan
M impact | EARNINGS | Nov 03, 2026, 08:03 AM UTC
Action Square Swings to Operating Loss in Q3
Action Square reported a consolidated preliminary operating loss for the third quarter of 2026, versus a profit in the year-earlier period. Revenue was 32.86.
M impact | EARNINGS | Nov 03, 2026, 08:02 AM UTC
Marriott Beats Q3 Estimates, Adds Rooms and Returns $4B
M impact | EARNINGS | Nov 03, 2026, 08:02 AM UTC